The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Ehrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930
SGLT2 inhibition — a novel strategy for diabetes treatment
Chao, E. C., & Henry, R. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3180 · Cited by 822
Tripathy, D., Mohanty, P., Dhindsa, S., Syed, T., Ghanim, H., Aljada, A., & Dandona, P. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2882 · Cited by 660
Boden, G., Sargrad, K., Homko, C., Mozzoli, M., & Stein, T. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00006 · Cited by 542
The sodium/glucose cotransport family SLC5
Wright, E. M., & Turk, E. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1202-0 · Cited by 537
Yang, W.-S., Jeng, C.-Y., Wu, T.-J., Tanaka, S., Funahashi, T., Matsuzawa, Y., Wang, J.-P., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.376 · Cited by 405
Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter
Turk, E., Zabel, B., Mundlos, S., Dyer, J., & Wright, E. M. (1991) · Nature · doi:10.1038/350354a0 · Cited by 383
Hyperglycemia and the Pathobiology of Diabetic Complications
Aronson, D. (2008) · Advances In Cardiology · doi:10.1159/000115118 · Cited by 362
Leahy, J. L., Bonner-Weir, S., & Weir, G. C. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.442 · Cited by 357
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2008) · Diabetes Care · doi:10.2337/dc08-9016 · Cited by 326
The sodium/glucose cotransport family SLC5
Turk, E., & Wright, E. M. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1063-6 · Cited by 251
Heuvel, L. V. D., K., A., M., W., & L., M. (2002) · Human Genetics · doi:10.1007/s00439-002-0820-5 · Cited by 223
Zhang, L., Feng, Y., List, J., Kasichayanula, S., & Pfister, M. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01216.x · Cited by 171
Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter
Wells, R. G., Pajor, A. M., Kanai, Y., Turk, E., Wright, E. M., & Hediger, M. A. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.3.f459 · Cited by 166
Pajor, A. M., & Wright, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50557-9 · Cited by 162
Ji, G., Yang, Q., Hao, J., Guo, L., Chen, X., Hu, J., Leng, L., & Jiang, Z. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.036 · Cited by 129
Horton, E. S. (2009) · Obesity · doi:10.1038/oby.2009.388 · Cited by 126
Stahl, M., & Berger, W. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00110.x · Cited by 125
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Abdul‐Ghani, M. A., Norton, L., & DeFronzo, R. A. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0275-6 · Cited by 123
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis
Başkol, G., Başkol, M., & Koçer, D. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.02.006 · Cited by 121
Treatment of Nonalcoholic Fatty Liver: Present and Emerging Therapies
Angulo, P., & Lindor, K. D. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12931 · Cited by 116
Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., et al. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0713-z · Cited by 112
Self-citationFenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice
Carmona, M. C., Louche, K., Nibbelink, M. M., Prunet‐Marcassus, B., Bross, A., Desbazeille, M., Dacquet, C., Renard, P., Casteilla, L., & Pénicaud, L. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802943 · Cited by 89
Sodium-glucose cotransporter inhibitors for diabetes.
Isaji, M. (2007) · PubMed · Cited by 87
Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.
Rossetti, L. (1995) · PubMed · Cited by 87
Attenuation of oxidative stress in streptozotocin-induced diabetic rats by Eucalyptus globulus
Nakhaee, A., Bokaeian, M., Saravani, M., Farhangi, A. A., & Akbarzadeh, A. (2009) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-009-0075-1 · Cited by 75
Tahara, A., Matsuyama‐Yokono, A., & Shibasaki, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.015 · Cited by 73
Self-citationDiet, obesity and diabetes: a current update
Walker, C. G., Zariwala, M. G., Holness, M. J., & Sugden, M. C. (2006) · Clinical Science · doi:10.1042/cs20060150 · Cited by 68
Shams, M. E. E. (2011) · Scientia Pharmaceutica · doi:10.3797/scipharm.1104-21 · Cited by 59
Nonalcoholic fatty liver disease: is all the fat bad?
Clouston, A. D., & Powell, E. E. (2004) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2004.00574.x · Cited by 40
Taverna, M. J., Pacher, N., Bruzzo, F., et al. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00534.x · Cited by 29
Cited by
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
Lopaschuk, G. D., & Verma, S. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.02.004 · Cited by 894
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmstädter, J., Kröller-Schön, S., Münzel, T., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7092151 · Cited by 708
Kuchay, M. S., Krishan, S., Mishra, S. K., Farooqui, K. J., Singh, M. K., Wasir, J. S., Bansal, B., Kaur, P., Jevalikar, G., Gill, H. K., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0165 · Cited by 662
Mouton, A. J., Li, X., Hall, M. E., & Hall, J. E. (2020) · Circulation Research · doi:10.1161/circresaha.119.312321 · Cited by 546
Metadata
- Authors
- Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., Kobayashi, Y., Noda, A., Sasamata, M., & Shibasaki, M.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 715
- Issue
- 1-3
- Pages
- 246-255
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2095574383
- Cited by
- 310
- References
- 38
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.